Validation of the prognostic impact of copeptin in normotensive pulmonary embolism in a european multicentre study.

Back

ESC Premium Access

Validation of the prognostic impact of copeptin in normotensive pulmonary embolism in a european multicentre study.

Session: What is new in venous thromboembolism?

Topic: Acute pulmonary embolism

Speaker: Doctor K. Hellenkamp (Goettingen, DE)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Kristian Hellenkamp

University Medical Centre of Gottingen (UMG), Goettingen (Germany)

0 follower

6 more presentations in this session

Long-term effects of unprovoked venous thromboembolism on mortality and major cardiovascular events

Speaker: Doctor W. Chang (Tainan, TW)

Access

Abstract

Slides

Comparative safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism - a Danish nationwide study

Speaker: Ms C. Clausen (Hellerup, DK)

Access

Abstract

A novel experimental in vivo model of acute pulmonary embolism

Speaker: Doctor J. Schultz (Aarhus, DK)

Access

Abstract

Slides

The YEARS algorithm for suspected pulmonary embolism leads to much shorter diagnostic turnaround time than conventional algorithms

Speaker: Doctor E. Klok (Leiden, NL)

Access

Abstract

Slides

Recurrent venous thromboembolism and major bleeding in patients treated with rivaroxaban or warfarin for venous thromboembolism in routine practice

Speaker: Doctor C. Coleman (Storrs, US)

Access

Abstract

Slides

Access the full session

What is new in venous thromboembolism?

Speakers: Doctor K. Hellenkamp, Doctor W. Chang, Ms C. Clausen, Doctor J. Schultz, Doctor E. Klok...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources